Showing results (971-980 of 1,262) with videos related to
Sort By:
Pageof 127
British Journal of Pharmacology|May 22, 2025
Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcriptionPatrick G Schweickert, Dana Piovesan, Casey G Mitchell, et al.Health Technology Assessment (Winchester, England)|August 27, 2010
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinenceM Imamura, P Abrams, C Bain, et al.Journal of Neuro-Oncology|September 21, 2010
KIT expression and methylation in medulloblastoma and PNET cell lines and tumorsMónica Enguita-Germán, Mikel Gurrea, Paula Schiapparelli, et al.Nature|February 9, 2018
Isomer depletion as experimental evidence of nuclear excitation by electron captureC J Chiara, J J Carroll, M P Carpenter, et al.Oncogene|November 11, 2009
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profilingA H Beck, C-H Lee, D M Witten, et al.Cancer Research|April 18, 2024
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T CellsDana Piovesan, Amber E de Groot, Soonweng Cho, et al.Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|May 1, 1983
Total synthesis of yeast alanine transfer ribonucleic acidD B Wang, K Q Zheng, M S Qiu, et al.Antimicrobial Agents and Chemotherapy|July 25, 2012
Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitorsM J Lamarche, J Borawski, A Bose, et al.Health Technology Assessment (Winchester, England)|September 29, 2011
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluationC Robertson, S K Arcot Ragupathy, C Boachie, et al.Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetS Horvath, B Zhang, M Carlson, et al.Pageof 127